We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 32.00 | 0.29% | 10,946.00 | 10,952.00 | 10,954.00 | 10,954.00 | 10,764.00 | 10,914.00 | 1,402,659 | 16:35:03 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 28.51 | 169.81B |
From Apr 2021 to Apr 2024
By Ian Walker
AstraZeneca PLC said Friday that it welcomed a decision by the Court of First Instance in Brussels to reduce the number of Covid-19 vaccine doses due to be delivered to the European Union by September.
The pharmaceutical giant said that the court has ordered that 80.2 million doses of the vaccine be delivered by Sept. 27. The European Commission had requested 120 million vaccine doses cumulatively by the end of June, and a total of 300 million doses by the end of September.
AstraZeneca said it has supplied more than 70 million doses of the vaccine to the EU and expects to "substantially exceed" the required amount by the end of June.
"AstraZeneca has fully complied with its agreement with the European Commission and we will continue to focus on the urgent task of supplying an effective vaccine," General Counsel Jeffrey Pott said.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
June 18, 2021 08:36 ET (12:36 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
